United States Acne Vulgaris Treatment Market Report 2018

United States Acne Vulgaris Treatment Market Report 2018

1 Acne Vulgaris Treatment Overview

1.1 Product Overview and Scope of Acne Vulgaris Treatment

1.2 Classification of Acne Vulgaris Treatment by Product Category

1.2.1 United States Acne Vulgaris Treatment Market Size (Sales Volume) Comparison by Type (2013-2025)

1.2.2 United States Acne Vulgaris Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2017

1.2.3 CB-0601

1.2.4 CJM-112

1.2.5 CLS-007

1.2.6 Dapsone

1.2.7 DFD-10

1.2.8 DLX-2323

1.2.9 Others

1.3 United States Acne Vulgaris Treatment Market by Application/End Users

1.3.1 United States Acne Vulgaris Treatment Market Size (Consumption) and Market Share Comparison by Application (2013-2025)

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 United States Acne Vulgaris Treatment Market by Region

1.4.1 United States Acne Vulgaris Treatment Market Size (Value) Comparison by Region (2013-2025)

1.4.2 The West Acne Vulgaris Treatment Status and Prospect (2013-2025)

1.4.3 Southwest Acne Vulgaris Treatment Status and Prospect (2013-2025)

1.4.4 The Middle Atlantic Acne Vulgaris Treatment Status and Prospect (2013-2025)

1.4.5 New England Acne Vulgaris Treatment Status and Prospect (2013-2025)

1.4.6 The South Acne Vulgaris Treatment Status and Prospect (2013-2025)

1.4.7 The Midwest Acne Vulgaris Treatment Status and Prospect (2013-2025)

1.5 United States Market Size (Value and Volume) of Acne Vulgaris Treatment (2013-2025)

1.5.1 United States Acne Vulgaris Treatment Sales and Growth Rate (2013-2025)

1.5.2 United States Acne Vulgaris Treatment Revenue and Growth Rate (2013-2025)

2 United States Acne Vulgaris Treatment Market Competition by Players/Suppliers

2.1 United States Acne Vulgaris Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)

2.2 United States Acne Vulgaris Treatment Revenue and Share by Players/Suppliers (2013-2018)

2.3 United States Acne Vulgaris Treatment Average Price by Players/Suppliers (2013-2018)

2.4 United States Acne Vulgaris Treatment Market Competitive Situation and Trends

2.4.1 United States Acne Vulgaris Treatment Market Concentration Rate

2.4.2 United States Acne Vulgaris Treatment Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Acne Vulgaris Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 United States Acne Vulgaris Treatment Sales (Volume) and Revenue (Value) by Region (2013-2018)

3.1 United States Acne Vulgaris Treatment Sales and Market Share by Region (2013-2018)

3.2 United States Acne Vulgaris Treatment Revenue and Market Share by Region (2013-2018)

3.3 United States Acne Vulgaris Treatment Price by Region (2013-2018)

4 United States Acne Vulgaris Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)

4.1 United States Acne Vulgaris Treatment Sales and Market Share by Type (Product Category) (2013-2018)

4.2 United States Acne Vulgaris Treatment Revenue and Market Share by Type (2013-2018)

4.3 United States Acne Vulgaris Treatment Price by Type (2013-2018)

4.4 United States Acne Vulgaris Treatment Sales Growth Rate by Type (2013-2018)

5 United States Acne Vulgaris Treatment Sales (Volume) by Application (2013-2018)

5.1 United States Acne Vulgaris Treatment Sales and Market Share by Application (2013-2018)

5.2 United States Acne Vulgaris Treatment Sales Growth Rate by Application (2013-2018)

5.3 Market Drivers and Opportunities

6 United States Acne Vulgaris Treatment Players/Suppliers Profiles and Sales Data

6.1 Common Pharma Inc

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Acne Vulgaris Treatment Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Common Pharma Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)

6.1.4 Main Business/Business Overview

6.2 Cutanea Life Sciences Inc

6.2.2 Acne Vulgaris Treatment Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)

6.2.4 Main Business/Business Overview

6.3 Dermira Inc

6.3.2 Acne Vulgaris Treatment Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Dermira Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)

6.3.4 Main Business/Business Overview

6.4 ELORAC Inc

6.4.2 Acne Vulgaris Treatment Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 ELORAC Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)

6.4.4 Main Business/Business Overview

6.5 Ensol Biosciences Inc

6.5.2 Acne Vulgaris Treatment Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)

6.5.4 Main Business/Business Overview

6.6 Foamix Pharmaceuticals Ltd

6.6.2 Acne Vulgaris Treatment Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)

6.6.4 Main Business/Business Overview

6.7 Galderma SA

6.7.2 Acne Vulgaris Treatment Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Galderma SA Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)

6.7.4 Main Business/Business Overview

6.8 GlaxoSmithKline Plc

6.8.2 Acne Vulgaris Treatment Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)

6.8.4 Main Business/Business Overview

6.9 Helix BioMedix Inc

6.9.2 Acne Vulgaris Treatment Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)

6.9.4 Main Business/Business Overview

6.10 Hovione FarmaCiencia SA

6.10.2 Acne Vulgaris Treatment Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Sales, Revenue, Price and Gross Margin (2013-2018)

6.10.4 Main Business/Business Overview

6.11 Lee's Pharmaceutical Holdings Ltd

6.12 LEO Pharma A/S

6.13 Novabiotics Ltd

6.14 Novan Inc

6.15 Novartis AG

6.16 Paratek Pharmaceuticals Inc

6.17 Pfizer Inc

6.18 Phosphagenics Ltd

7 Acne Vulgaris Treatment Manufacturing Cost Analysis

7.1 Acne Vulgaris Treatment Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Acne Vulgaris Treatment

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Acne Vulgaris Treatment Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Acne Vulgaris Treatment Major Manufacturers in 2017

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Acne Vulgaris Treatment Market Size (Value and Volume) Forecast (2018-2025)

11.1 United States Acne Vulgaris Treatment Sales Volume, Revenue Forecast (2018-2025)

11.2 United States Acne Vulgaris Treatment Sales Volume Forecast by Type (2018-2025)

11.3 United States Acne Vulgaris Treatment Sales Volume Forecast by Application (2018-2025)

11.4 United States Acne Vulgaris Treatment Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Acne Vulgaris Treatment

Figure United States Acne Vulgaris Treatment Market Size (K Pcs) by Type (2013-2025)

Figure United States Acne Vulgaris Treatment Sales Volume Market Share by Type (Product Category) in 2017

Figure CB-0601 Product Picture

Figure CJM-112 Product Picture

Figure CLS-007 Product Picture

Figure Dapsone Product Picture

Figure DFD-10 Product Picture

Figure DLX-2323 Product Picture

Figure Others Product Picture

Figure United States Acne Vulgaris Treatment Market Size (K Pcs) by Application (2013-2025)

Figure United States Sales Market Share of Acne Vulgaris Treatment by Application in 2017

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Acne Vulgaris Treatment Market Size (Million USD) by Region (2013-2025)

Figure The West Acne Vulgaris Treatment Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southwest Acne Vulgaris Treatment Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Middle Atlantic Acne Vulgaris Treatment Revenue (Million USD) and Growth Rate (2013-2025)

Figure New England Acne Vulgaris Treatment Revenue (Million USD) and Growth Rate (2013-2025)

Figure The South of US Acne Vulgaris Treatment Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Midwest Acne Vulgaris Treatment Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Acne Vulgaris Treatment Sales (K Pcs) and Growth Rate (2013-2025)

Figure United States Acne Vulgaris Treatment Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Acne Vulgaris Treatment Market Major Players Product Sales Volume (K Pcs) (2013-2018)

Table United States Acne Vulgaris Treatment Sales (K Pcs) of Key Players/Suppliers (2013-2018)

Table United States Acne Vulgaris Treatment Sales Share by Players/Suppliers (2013-2018)

Figure 2017 United States Acne Vulgaris Treatment Sales Share by Players/Suppliers

Figure 2017 United States Acne Vulgaris Treatment Sales Share by Players/Suppliers

Figure United States Acne Vulgaris Treatment Market Major Players Product Revenue (Million USD) (2013-2018)

Table United States Acne Vulgaris Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)

Table United States Acne Vulgaris Treatment Revenue Share by Players/Suppliers (2013-2018)

Figure 2017 United States Acne Vulgaris Treatment Revenue Share by Players/Suppliers

Figure 2017 United States Acne Vulgaris Treatment Revenue Share by Players/Suppliers

Table United States Market Acne Vulgaris Treatment Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)

Figure United States Market Acne Vulgaris Treatment Average Price (USD/Pcs) of Key Players/Suppliers in 2017

Figure United States Acne Vulgaris Treatment Market Share of Top 3 Players/Suppliers

Figure United States Acne Vulgaris Treatment Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Acne Vulgaris Treatment Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Acne Vulgaris Treatment Product Category

Table United States Acne Vulgaris Treatment Sales (K Pcs) by Region (2013-2018)

Table United States Acne Vulgaris Treatment Sales Share by Region (2013-2018)

Figure United States Acne Vulgaris Treatment Sales Share by Region (2013-2018)

Figure United States Acne Vulgaris Treatment Sales Market Share by Region in 2017

Table United States Acne Vulgaris Treatment Revenue (Million USD) and Market Share by Region (2013-2018)

Table United States Acne Vulgaris Treatment Revenue Share by Region (2013-2018)

Figure United States Acne Vulgaris Treatment Revenue Market Share by Region (2013-2018)

Figure United States Acne Vulgaris Treatment Revenue Market Share by Region in 2017

Table United States Acne Vulgaris Treatment Price (USD/Pcs) by Region (2013-2018)

Table United States Acne Vulgaris Treatment Sales (K Pcs) by Type (2013-2018)

Table United States Acne Vulgaris Treatment Sales Share by Type (2013-2018)

Figure United States Acne Vulgaris Treatment Sales Share by Type (2013-2018)

Figure United States Acne Vulgaris Treatment Sales Market Share by Type in 2017

Table United States Acne Vulgaris Treatment Revenue (Million USD) and Market Share by Type (2013-2018)

Table United States Acne Vulgaris Treatment Revenue Share by Type (2013-2018)

Figure Revenue Market Share of Acne Vulgaris Treatment by Type (2013-2018)

Figure Revenue Market Share of Acne Vulgaris Treatment by Type in 2017

Table United States Acne Vulgaris Treatment Price (USD/Pcs) by Types (2013-2018)

Figure United States Acne Vulgaris Treatment Sales Growth Rate by Type (2013-2018)

Table United States Acne Vulgaris Treatment Sales (K Pcs) by Application (2013-2018)

Table United States Acne Vulgaris Treatment Sales Market Share by Application (2013-2018)

Figure United States Acne Vulgaris Treatment Sales Market Share by Application (2013-2018)

Figure United States Acne Vulgaris Treatment Sales Market Share by Application in 2017

Table United States Acne Vulgaris Treatment Sales Growth Rate by Application (2013-2018)

Figure United States Acne Vulgaris Treatment Sales Growth Rate by Application (2013-2018)

Table Common Pharma Inc Basic Information List

Table Common Pharma Inc Acne Vulgaris Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Common Pharma Inc Acne Vulgaris Treatment Sales Growth Rate (2013-2018)

Figure Common Pharma Inc Acne Vulgaris Treatment Sales Market Share in United States (2013-2018)

Figure Common Pharma Inc Acne Vulgaris Treatment Revenue Market Share in United States (2013-2018)

Table Cutanea Life Sciences Inc Basic Information List

Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Cutanea Life Sciences Inc Acne Vulgaris Treatment Sales Growth Rate (2013-2018)

Figure Cutanea Life Sciences Inc Acne Vulgaris Treatment Sales Market Share in United States (2013-2018)

Figure Cutanea Life Sciences Inc Acne Vulgaris Treatment Revenue Market Share in United States (2013-2018)

Table Dermira Inc Basic Information List

Table Dermira Inc Acne Vulgaris Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Dermira Inc Acne Vulgaris Treatment Sales Growth Rate (2013-2018)

Figure Dermira Inc Acne Vulgaris Treatment Sales Market Share in United States (2013-2018)

Figure Dermira Inc Acne Vulgaris Treatment Revenue Market Share in United States (2013-2018)

Table ELORAC Inc Basic Information List

Table ELORAC Inc Acne Vulgaris Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure ELORAC Inc Acne Vulgaris Treatment Sales Growth Rate (2013-2018)

Figure ELORAC Inc Acne Vulgaris Treatment Sales Market Share in United States (2013-2018)

Figure ELORAC Inc Acne Vulgaris Treatment Revenue Market Share in United States (2013-2018)

Table Ensol Biosciences Inc Basic Information List

Table Ensol Biosciences Inc Acne Vulgaris Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Ensol Biosciences Inc Acne Vulgaris Treatment Sales Growth Rate (2013-2018)

Figure Ensol Biosciences Inc Acne Vulgaris Treatment Sales Market Share in United States (2013-2018)

Figure Ensol Biosciences Inc Acne Vulgaris Treatment Revenue Market Share in United States (2013-2018)

Table Foamix Pharmaceuticals Ltd Basic Information List

Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Sales Growth Rate (2013-2018)

Figure Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Sales Market Share in United States (2013-2018)

Figure Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Revenue Market Share in United States (2013-2018)

Table Galderma SA Basic Information List

Table Galderma SA Acne Vulgaris Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Galderma SA Acne Vulgaris Treatment Sales Growth Rate (2013-2018)

Figure Galderma SA Acne Vulgaris Treatment Sales Market Share in United States (2013-2018)

Figure Galderma SA Acne Vulgaris Treatment Revenue Market Share in United States (2013-2018)

Table GlaxoSmithKline Plc Basic Information List

Table GlaxoSmithKline Plc Acne Vulgaris Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure GlaxoSmithKline Plc Acne Vulgaris Treatment Sales Growth Rate (2013-2018)

Figure GlaxoSmithKline Plc Acne Vulgaris Treatment Sales Market Share in United States (2013-2018)

Figure GlaxoSmithKline Plc Acne Vulgaris Treatment Revenue Market Share in United States (2013-2018)

Table Helix BioMedix Inc Basic Information List

Table Helix BioMedix Inc Acne Vulgaris Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Helix BioMedix Inc Acne Vulgaris Treatment Sales Growth Rate (2013-2018)

Figure Helix BioMedix Inc Acne Vulgaris Treatment Sales Market Share in United States (2013-2018)

Figure Helix BioMedix Inc Acne Vulgaris Treatment Revenue Market Share in United States (2013-2018)

Table Hovione FarmaCiencia SA Basic Information List

Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Hovione FarmaCiencia SA Acne Vulgaris Treatment Sales Growth Rate (2013-2018)

Figure Hovione FarmaCiencia SA Acne Vulgaris Treatment Sales Market Share in United States (2013-2018)

Figure Hovione FarmaCiencia SA Acne Vulgaris Treatment Revenue Market Share in United States (2013-2018)

Table Lee's Pharmaceutical Holdings Ltd Basic Information List

Table LEO Pharma A/S Basic Information List

Table Novabiotics Ltd Basic Information List

Table Novan Inc Basic Information List

Table Novartis AG Basic Information List

Table Paratek Pharmaceuticals Inc Basic Information List

Table Pfizer Inc Basic Information List

Table Phosphagenics Ltd Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Acne Vulgaris Treatment

Figure Manufacturing Process Analysis of Acne Vulgaris Treatment

Figure Acne Vulgaris Treatment Industrial Chain Analysis

Table Raw Materials Sources of Acne Vulgaris Treatment Major Players/Suppliers in 2017

Table Major Buyers of Acne Vulgaris Treatment

Table Distributors/Traders List

Figure United States Acne Vulgaris Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)

Figure United States Acne Vulgaris Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure United States Acne Vulgaris Treatment Price (USD/Pcs) Trend Forecast (2018-2025)

Table United States Acne Vulgaris Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025)

Figure United States Acne Vulgaris Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025)

Figure United States Acne Vulgaris Treatment Sales Volume (K Pcs) Forecast by Type in 2025

Table United States Acne Vulgaris Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025)

Figure United States Acne Vulgaris Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025)

Figure United States Acne Vulgaris Treatment Sales Volume (K Pcs) Forecast by Application in 2025

Table United States Acne Vulgaris Treatment Sales Volume (K Pcs) Forecast by Region (2018-2025)

Table United States Acne Vulgaris Treatment Sales Volume Share Forecast by Region (2018-2025)

Figure United States Acne Vulgaris Treatment Sales Volume Share Forecast by Region (2018-2025)

Figure United States Acne Vulgaris Treatment Sales Volume Share Forecast by Region in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources